Reasons why liver function remains normal after taking Erdafitinib for three years
After three years of taking Erdafitinib (Erdafitinib), his liver function remains normal. First of all, this is due to the good safety and tolerability of the drug. As an oral tyrosine kinase inhibitor, erdafitinib is designed with drug metabolism and toxicity in mind to avoid excessive burden on the liver. Clinical studies have shown that although erdafitinib may cause mild fluctuations in some liver function indicators, the liver function of most patients can remain stable without serious liver damage.
Secondly, patients usually undergo regular liver function testing and medical monitoring during long-term treatment with erdafitinib. This kind of regular examination can detect liver abnormalities in time, and doctors can adjust the medication plan or take protective measures based on the test results to avoid liver damage to the greatest extent. If the patient himself has no underlying liver disease and follows the doctor's advice and takes medication rationally, the risk of abnormal liver function will naturally be greatly reduced.
In addition, individual differences are also one of the important reasons why liver function remains normal. Different patients have different liver metabolism capabilities, genetic backgrounds and lifestyle habits, which will affect the metabolism and excretion of drugs in the body. Some patients may be born with stronger liver function, which can better process the metabolites of erdafitinib, reduce the burden on the liver, and thus maintain stable liver function in the long term.
Finally, the patient's own health management also plays a key role. Eating a reasonable diet, avoiding the use of alcohol and hepatotoxic drugs, and maintaining good lifestyle habits can all help protect liver function. Based on the above factors, the patient's liver function is still normal after taking erdafitinib for three years, which is the result of the combination of drug safety, medical monitoring, individual differences and health management.
Reference link:https://www.balversa.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)